Vertex Pharmaceuticals Incorporated (VRTX)
USD 501.15
(0.46%)
USD 501.15
(0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.86 Billion USD | 10.17% |
| 2022 | 8.93 Billion USD | 17.91% |
| 2021 | 7.57 Billion USD | 22.06% |
| 2020 | 6.2 Billion USD | 49.07% |
| 2019 | 4.16 Billion USD | 36.59% |
| 2018 | 3.04 Billion USD | 22.46% |
| 2017 | 2.48 Billion USD | 46.2% |
| 2016 | 1.7 Billion USD | 64.89% |
| 2015 | 1.03 Billion USD | 77.86% |
| 2014 | 580.41 Million USD | -52.11% |
| 2013 | 1.21 Billion USD | -20.63% |
| 2012 | 1.52 Billion USD | 8.25% |
| 2011 | 1.41 Billion USD | 883.91% |
| 2010 | 143.37 Million USD | 40.49% |
| 2009 | 102.04 Million USD | -41.85% |
| 2008 | 175.5 Million USD | -11.81% |
| 2007 | 199.01 Million USD | -8.02% |
| 2006 | 216.35 Million USD | 34.47% |
| 2005 | 160.89 Million USD | 56.63% |
| 2004 | 102.71 Million USD | 48.56% |
| 2003 | 69.14 Million USD | -57.08% |
| 2002 | 161.08 Million USD | -3.82% |
| 2001 | 167.49 Million USD | 114.38% |
| 2000 | 78.12 Million USD | 26.83% |
| 1999 | 61.6 Million USD | 38.74% |
| 1998 | 44.4 Million USD | 1.37% |
| 1997 | 43.8 Million USD | 229.32% |
| 1996 | 13.3 Million USD | -39.82% |
| 1995 | 22.1 Million USD | 12.76% |
| 1994 | 19.6 Million USD | -29.75% |
| 1993 | 27.9 Million USD | 634.21% |
| 1992 | 3.8 Million USD | 18.75% |
| 1991 | 3.2 Million USD | 39.13% |
| 1990 | 2.3 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.68 Billion USD | 6.73% |
| 2024 Q3 | 2.77 Billion USD | 5.21% |
| 2024 Q2 | 2.63 Billion USD | -1.95% |
| 2023 FY | 9.83 Billion USD | 10.17% |
| 2023 Q1 | 2.37 Billion USD | 3.13% |
| 2023 Q2 | 2.49 Billion USD | 4.99% |
| 2023 Q4 | 2.51 Billion USD | 1.38% |
| 2023 Q3 | 2.48 Billion USD | -0.39% |
| 2022 Q2 | 2.19 Billion USD | 4.71% |
| 2022 FY | 8.93 Billion USD | 17.91% |
| 2022 Q4 | 2.3 Billion USD | -1.35% |
| 2022 Q1 | 2.09 Billion USD | 1.2% |
| 2022 Q3 | 2.33 Billion USD | 6.29% |
| 2021 Q3 | 1.98 Billion USD | 10.64% |
| 2021 FY | 7.57 Billion USD | 22.06% |
| 2021 Q1 | 1.72 Billion USD | 5.93% |
| 2021 Q4 | 2.07 Billion USD | 4.46% |
| 2021 Q2 | 1.79 Billion USD | 4.01% |
| 2020 Q2 | 1.52 Billion USD | 0.62% |
| 2020 Q1 | 1.51 Billion USD | 7.21% |
| 2020 FY | 6.2 Billion USD | 49.07% |
| 2020 Q3 | 1.53 Billion USD | 0.9% |
| 2020 Q4 | 1.62 Billion USD | 5.82% |
| 2019 FY | 4.16 Billion USD | 36.59% |
| 2019 Q3 | 949.82 Million USD | 0.91% |
| 2019 Q2 | 941.29 Million USD | 9.65% |
| 2019 Q4 | 1.41 Billion USD | 48.79% |
| 2019 Q1 | 858.43 Million USD | -1.34% |
| 2018 Q1 | 640.79 Million USD | -1.66% |
| 2018 Q2 | 752.15 Million USD | 17.38% |
| 2018 Q3 | 784.53 Million USD | 4.3% |
| 2018 FY | 3.04 Billion USD | 22.46% |
| 2018 Q4 | 870.1 Million USD | 10.91% |
| 2017 Q4 | 651.63 Million USD | 12.71% |
| 2017 Q1 | 714.71 Million USD | 55.81% |
| 2017 Q2 | 544.13 Million USD | -23.87% |
| 2017 FY | 2.48 Billion USD | 46.2% |
| 2017 Q3 | 578.16 Million USD | 6.25% |
| 2016 Q2 | 431.6 Million USD | 8.42% |
| 2016 FY | 1.7 Billion USD | 64.89% |
| 2016 Q4 | 458.7 Million USD | 10.86% |
| 2016 Q3 | 413.78 Million USD | -4.13% |
| 2016 Q1 | 398.08 Million USD | -4.75% |
| 2015 Q2 | 166.07 Million USD | 19.9% |
| 2015 Q4 | 417.93 Million USD | 34.9% |
| 2015 FY | 1.03 Billion USD | 77.86% |
| 2015 Q3 | 309.81 Million USD | 86.55% |
| 2015 Q1 | 138.5 Million USD | -4.18% |
| 2014 Q4 | 144.55 Million USD | -19.24% |
| 2014 FY | 580.41 Million USD | -52.11% |
| 2014 Q2 | 138.42 Million USD | 16.86% |
| 2014 Q1 | 118.45 Million USD | -66.27% |
| 2014 Q3 | 178.98 Million USD | 29.31% |
| 2013 Q1 | 328.36 Million USD | -1.68% |
| 2013 FY | 1.21 Billion USD | -20.63% |
| 2013 Q4 | 351.15 Million USD | 58.39% |
| 2013 Q2 | 310.75 Million USD | -5.37% |
| 2013 Q3 | 221.7 Million USD | -28.66% |
| 2012 Q1 | 438.73 Million USD | -22.12% |
| 2012 Q2 | 418.3 Million USD | -4.66% |
| 2012 FY | 1.52 Billion USD | 8.25% |
| 2012 Q3 | 336 Million USD | -19.67% |
| 2012 Q4 | 333.99 Million USD | -0.6% |
| 2011 Q2 | 114.42 Million USD | 55.34% |
| 2011 Q3 | 659.2 Million USD | 476.1% |
| 2011 Q4 | 563.34 Million USD | -14.54% |
| 2011 FY | 1.41 Billion USD | 883.91% |
| 2011 Q1 | 73.66 Million USD | 12.42% |
| 2010 Q2 | 31.62 Million USD | 40.99% |
| 2010 Q3 | 23.79 Million USD | -24.75% |
| 2010 FY | 143.37 Million USD | 40.49% |
| 2010 Q4 | 65.52 Million USD | 175.37% |
| 2010 Q1 | 22.42 Million USD | -33.82% |
| 2009 Q1 | 23.97 Million USD | -26.92% |
| 2009 Q3 | 24.95 Million USD | 30.91% |
| 2009 Q2 | 19.06 Million USD | -20.5% |
| 2009 FY | 102.04 Million USD | -41.85% |
| 2009 Q4 | 33.88 Million USD | 35.79% |
| 2008 FY | 175.5 Million USD | -11.81% |
| 2008 Q4 | 32.81 Million USD | 3.8% |
| 2008 Q3 | 31.6 Million USD | -54.46% |
| 2008 Q2 | 69.4 Million USD | 66.55% |
| 2008 Q1 | 41.67 Million USD | -18.27% |
| 2007 FY | 199.01 Million USD | -8.02% |
| 2007 Q2 | 38.19 Million USD | -44.49% |
| 2007 Q4 | 50.99 Million USD | 24.33% |
| 2007 Q3 | 41.01 Million USD | 7.38% |
| 2007 Q1 | 68.81 Million USD | -27.0% |
| 2006 FY | 216.35 Million USD | 34.47% |
| 2006 Q1 | 39.08 Million USD | -38.69% |
| 2006 Q4 | 94.25 Million USD | 76.87% |
| 2006 Q3 | 53.28 Million USD | 79.27% |
| 2006 Q2 | 29.72 Million USD | -23.95% |
| 2005 FY | 160.89 Million USD | 56.63% |
| 2005 Q4 | 63.75 Million USD | 76.09% |
| 2005 Q3 | 36.2 Million USD | 12.02% |
| 2005 Q2 | 32.32 Million USD | 12.99% |
| 2005 Q1 | 28.6 Million USD | -28.19% |
| 2004 FY | 102.71 Million USD | 48.56% |
| 2004 Q3 | 26.82 Million USD | 44.7% |
| 2004 Q1 | 17.51 Million USD | 65.15% |
| 2004 Q4 | 39.83 Million USD | 48.48% |
| 2004 Q2 | 18.54 Million USD | 5.87% |
| 2003 Q3 | 18.35 Million USD | 4.42% |
| 2003 Q2 | 17.57 Million USD | -22.26% |
| 2003 Q4 | 10.6 Million USD | -42.22% |
| 2003 FY | 69.14 Million USD | -57.08% |
| 2003 Q1 | 22.6 Million USD | -48.36% |
| 2002 Q1 | 40.69 Million USD | -21.02% |
| 2002 Q2 | 42.33 Million USD | 4.02% |
| 2002 FY | 161.08 Million USD | -3.82% |
| 2002 Q3 | 34.27 Million USD | -19.03% |
| 2002 Q4 | 43.78 Million USD | 27.74% |
| 2001 Q2 | 21.44 Million USD | 12.52% |
| 2001 Q1 | 19.05 Million USD | -3.28% |
| 2001 FY | 167.49 Million USD | 114.38% |
| 2001 Q4 | 51.52 Million USD | 27.64% |
| 2001 Q3 | 40.36 Million USD | 88.26% |
| 2000 Q1 | 7.52 Million USD | -74.58% |
| 2000 FY | 78.12 Million USD | 26.83% |
| 2000 Q4 | 19.7 Million USD | 42.1% |
| 2000 Q3 | 13.86 Million USD | -62.56% |
| 2000 Q2 | 37.03 Million USD | 392.28% |
| 1999 Q2 | 15.3 Million USD | 282.5% |
| 1999 Q3 | 9.6 Million USD | -37.25% |
| 1999 Q4 | 29.6 Million USD | 208.33% |
| 1999 FY | 61.6 Million USD | 38.74% |
| 1999 Q1 | 4 Million USD | -65.81% |
| 1998 Q2 | 7.2 Million USD | 125.0% |
| 1998 FY | 44.4 Million USD | 1.37% |
| 1998 Q1 | 3.2 Million USD | -71.43% |
| 1998 Q3 | 18.4 Million USD | 155.56% |
| 1998 Q4 | 11.7 Million USD | -36.41% |
| 1997 Q1 | 6.9 Million USD | 43.75% |
| 1997 Q2 | 12.2 Million USD | 76.81% |
| 1997 FY | 43.8 Million USD | 229.32% |
| 1997 Q4 | 11.2 Million USD | -17.04% |
| 1997 Q3 | 13.5 Million USD | 10.66% |
| 1996 FY | 13.3 Million USD | -39.82% |
| 1996 Q3 | 2.9 Million USD | -6.45% |
| 1996 Q2 | 3.1 Million USD | 24.0% |
| 1996 Q4 | 4.8 Million USD | 65.52% |
| 1996 Q1 | 2.5 Million USD | -69.51% |
| 1995 Q1 | 5.1 Million USD | 88.89% |
| 1995 Q4 | 8.2 Million USD | 256.52% |
| 1995 Q3 | 2.3 Million USD | -64.62% |
| 1995 Q2 | 6.5 Million USD | 27.45% |
| 1995 FY | 22.1 Million USD | 12.76% |
| 1994 Q3 | 6.5 Million USD | 35.42% |
| 1994 FY | 19.6 Million USD | -29.75% |
| 1994 Q1 | 5.6 Million USD | -68.89% |
| 1994 Q2 | 4.8 Million USD | -14.29% |
| 1994 Q4 | 2.7 Million USD | -58.46% |
| 1993 Q4 | 18 Million USD | 309.09% |
| 1993 FY | 27.9 Million USD | 634.21% |
| 1993 Q1 | 900 Thousand USD | -10.0% |
| 1993 Q2 | 4.6 Million USD | 411.11% |
| 1993 Q3 | 4.4 Million USD | -4.35% |
| 1992 Q4 | 1 Million USD | 0.0% |
| 1992 Q2 | 1 Million USD | 11.11% |
| 1992 FY | 3.8 Million USD | 18.75% |
| 1992 Q1 | 900 Thousand USD | 12.5% |
| 1992 Q3 | 1 Million USD | 0.0% |
| 1991 FY | 3.2 Million USD | 39.13% |
| 1991 Q1 | 800 Thousand USD | 33.33% |
| 1991 Q3 | 800 Thousand USD | 0.0% |
| 1991 Q2 | 800 Thousand USD | 0.0% |
| 1991 Q4 | 800 Thousand USD | 0.0% |
| 1990 Q3 | 600 Thousand USD | 0.0% |
| 1990 Q1 | 500 Thousand USD | 0.0% |
| 1990 FY | 2.3 Million USD | 0.0% |
| 1990 Q4 | 600 Thousand USD | 0.0% |
| 1990 Q2 | 600 Thousand USD | 20.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Absci Corporation | 5.71 Million USD | -172498.811% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -5696.002% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -439.804% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 821 Thousand USD | -1201995.006% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 26.97 Million USD | -36485.113% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -1230473.566% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -715059.42% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -29030.73% |
| Chimerix, Inc. | 324 Thousand USD | -3045949.383% |
| CRISPR Therapeutics AG | 371.2 Million USD | -2558.685% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -19638.4% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -21346.391% |
| Fortress Biotech, Inc. | 84.51 Million USD | -11577.73% |
| Fortress Biotech, Inc. | 84.51 Million USD | -11577.73% |
| Gritstone bio, Inc. | 1.33 Million USD | -741387.603% |
| Allakos Inc. | - USD | -Infinity% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -46967.913% |
| Cytokinetics, Incorporated | 7.53 Million USD | -130965.073% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| Innoviva, Inc. | 310.46 Million USD | -3078.865% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 17.47 Million USD | -56386.876% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -42103.122% |
| Incyte Corporation | 3.69 Billion USD | -167.049% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -1186087.666% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -4362787.254% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| MiMedx Group, Inc. | 321.47 Million USD | -2969.955% |
| MEI Pharma, Inc. | 65.29 Million USD | -15014.324% |
| MacroGenics, Inc. | 58.74 Million USD | -16698.924% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 10 Million USD | -98592.0% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -297961.117% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -31747.43% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -3315.598% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| NextCure, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -357479.71% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -51709.544% |
| Onconetix, Inc. | 58.46 Thousand USD | -16880426.811% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -1257122.93% |
| Opthea Limited | 261.85 Thousand USD | -3768798.529% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -2519513.475% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -158441.365% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -22953.492% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -296272.372% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 24.761% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -8343.73% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -85126.252% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -24573.0% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -5500.118% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 2.87 Million USD | -342699.583% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -6319.785% |
| TG Therapeutics, Inc. | 233.66 Million USD | -4123.708% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -126949.434% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -5363595.652% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -6695.191% |
| UroGen Pharma Ltd. | 82.71 Million USD | -11831.861% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -192507.338% |
| XOMA Corporation | 4.75 Million USD | -207323.287% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| AbCellera Biologics Inc. | 38.02 Million USD | -25854.504% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Precision BioSciences, Inc. | 48.72 Million USD | -20154.069% |
| Dyadic International, Inc. | 2.89 Million USD | -340357.416% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -31090.19% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -2327541.509% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -463242.723% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -281877.143% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -7415.726% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -3788460.461% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -6156.308% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -99227.697% |
| Senti Biosciences, Inc. | 2.56 Million USD | -385265.092% |
| Mesoblast Limited | 5.9 Million USD | -167117.892% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -12457.512% |
| ChromaDex Corporation | 83.57 Million USD | -11709.501% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -4970.932% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 15.18 Million USD | -64905.928% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -5920.962% |
| Novavax, Inc. | 983.7 Million USD | -903.268% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -15433.974% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -9581647.573% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -7591592.308% |
| Celcuity Inc. | - USD | -Infinity% |
| ContextLogic Inc. | 287 Million USD | -3338.746% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -1446996.774% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -48929.758% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | -157.399% |
| Amarin Corporation plc | 306.91 Million USD | -3115.655% |
| AnaptysBio, Inc. | 17.15 Million USD | -57422.877% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 431.37 Thousand USD | -2287731.09% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -37852.623% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -3999.612% |
| Ardelyx, Inc. | 124.45 Million USD | -7829.871% |
| Celularity Inc. | 22.77 Million USD | -43241.092% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -3856.733% |
| IO Biotech, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -197383900.0% |
| Pulmatrix, Inc. | 7.29 Million USD | -135131.57% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -27106.616% |
| Evogene Ltd. | 5.64 Million USD | -174885.816% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -205508.333% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -927456.391% |
| Sagimet Biosciences Inc. | 2 Million USD | -493360.0% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -952.353% |
| scPharmaceuticals Inc. | 13.59 Million USD | -72505.017% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -351743.137% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -1945.96% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -112305.467% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 2.8 Million USD | -351381.631% |
| bluebird bio, Inc. | 29.49 Million USD | -33358.318% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | -307.949% |
| DBV Technologies S.A. | 15.72 Million USD | -62649.237% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -103134.31% |
| Galecto, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -97721.39% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -548188.889% |
| GlycoMimetics, Inc. | 10 Thousand USD | -98691900.0% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -16457.394% |
| ADMA Biologics, Inc. | 258.21 Million USD | -3722.086% |
| Clene Inc. | 654 Thousand USD | -1508951.988% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -22040.662% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -1175702.011% |
| Century Therapeutics, Inc. | 2.23 Million USD | -441474.944% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -46786.788% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -9650.825% |
| Autolus Therapeutics plc | 1.69 Million USD | -581124.971% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -14513429.412% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -28525.46% |
| GRI Bio, Inc. | 21.76 Million USD | -45240.194% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -388453.323% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -121998.231% |
| INmune Bio, Inc. | 155 Thousand USD | -6367125.806% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -7668.332% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -440687.837% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -101008.493% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -986820.0% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -119875.687% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -115019.561% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -3736.513% |
| Verastem, Inc. | - USD | -Infinity% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -624532.911% |
| Histogen Inc. | 3.76 Million USD | -261751.95% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -1692059.71% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -1258.576% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -9054211.927% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -143912.841% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -6768898.628% |
| Kronos Bio, Inc. | 6.28 Million USD | -156852.926% |
| Turnstone Biologics Corp. | 19.3 Million USD | -51019.859% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -7549.772% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -5523.059% |
| Exelixis, Inc. | 1.83 Billion USD | -439.239% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -12719.307% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -2388.508% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -6953.913% |
| Insmed Incorporated | 305.2 Million USD | -3133.598% |
| MediWound Ltd. | 18.68 Million USD | -52716.012% |
| OmniAb, Inc. | 34.16 Million USD | -28787.718% |
| Alector, Inc. | 97.06 Million USD | -10067.934% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -7712.547% |
| Zai Lab Limited | 266.71 Million USD | -3600.224% |
| AlloVir, Inc. | - USD | -Infinity% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -4116.886% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -56466.745% |
| Veracyte, Inc. | 361.05 Million USD | -2633.464% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -214553.753% |
| FibroGen, Inc. | 147.75 Million USD | -6579.571% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -2378.428% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -6677076.009% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -2349709.524% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -2491.797% |
| Fortrea Holdings Inc. | 3.1 Billion USD | -217.44% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -6535794.04% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -633353.145% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -28795.33% |
| Agenus Inc. | 156.31 Million USD | -6213.702% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -11535.601% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -17086.542% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -2172.705% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -21951.122% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -2877.925% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -17885365.748% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -47448.661% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -109657677.778% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -8081988.574% |
| Pluri Inc. | 326 Thousand USD | -3027261.963% |
| Prothena Corporation plc | 91.37 Million USD | -10701.357% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -16271.991% |
| Rallybio Corporation | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -179666.849% |
| MeiraGTx Holdings plc | 14.01 Million USD | -70308.789% |
| Annexon, Inc. | - USD | -Infinity% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -137680.26% |
| Moderna, Inc. | 6.84 Billion USD | -44.118% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -15343.549% |
| Blueprint Medicines Corporation | 249.38 Million USD | -3857.495% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -8610.295% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -197455.755% |
| Nutriband Inc. | 2.08 Million USD | -473171.651% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -7808.33% |
| Alkermes plc | 1.66 Billion USD | -493.313% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -98661.133% |
| Arcellx, Inc. | 110.31 Million USD | -8846.056% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -105986.209% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -26918.918% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -3142957.325% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 1 Million USD | -986820.0% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -403218.349% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -57832891.503% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -3547.154% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -4164119.409% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -47524.379% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -3551.756% |
| Royalty Pharma plc | 2.35 Billion USD | -319.154% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| BioAtla, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -10388531.579% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -26678.456% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| Kezar Life Sciences, Inc. | 7 Million USD | -140888.571% |
| aTyr Pharma, Inc. | 353 Thousand USD | -2795707.365% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -63453.352% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -3142957.325% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -81840848.669% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -1090.131% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -819600.997% |
| Liquidia Corporation | 17.48 Million USD | -56334.126% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Vericel Corporation | 197.51 Million USD | -4896.658% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -54302.734% |
| Xencor, Inc. | 168.33 Million USD | -5762.729% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -3891954.753% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -5023.131% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -4362787.254% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -57832891.503% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -656533.4% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -189518.916% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -634983.655% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -12646.293% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -89955.662% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | -324.026% |
| HilleVax, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -13687731.128% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | -3923.056% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -98365.529% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | -301.386% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -16348.667% |
| Erasca, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -123172.546% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -143285.152% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -2371.279% |
| Aditxt, Inc. | 645.17 Thousand USD | -1529591.123% |
| Adagene Inc. | 18.11 Million USD | -54391.372% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -912025.693% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -3847.554% |
| Compugen Ltd. | 33.45 Million USD | -29396.399% |
| Generation Bio Co. | 5.9 Million USD | -167061.247% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -38533.054% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -10102.305% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -9731.153% |
| Instil Bio, Inc. | - USD | -Infinity% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -39097.61% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -576171.681% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -11351.845% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -13498641.657% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -16786.881% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -83836.044% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -125207.263% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -1586588.103% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -181252.444% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -13970.114% |
| Celularity Inc. | 22.77 Million USD | -43241.092% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -245830.725% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -6309363.684% |
| Cibus, Inc. | 1.81 Million USD | -543059.053% |
| IN8bio, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -274044.444% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -512852.183% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -1152.998% |
| Eyenovia, Inc. | 3787.00 USD | -260607240.903% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -4088.307% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -2022277.049% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -12360.482% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -1090360.296% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -145699.97% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -1344714.007% |
| Humacyte, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -5805311.765% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Notable Labs, Ltd. | 310 Thousand USD | -3183512.903% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -912025.693% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -529932.223% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -207323.287% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -32897233.333% |
| Bionomics Limited | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -62193.757% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -15153.079% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -2316613.615% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -2682644.504% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -35838.968% |
| Benitec Biopharma Inc. | 216 Thousand USD | -4568974.074% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -1113805.192% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -704.784% |
| Immunome, Inc. | 14.01 Million USD | -70303.767% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -595506.518% |
| CervoMed Inc. | 7.14 Million USD | -138029.836% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -200779.3% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -349128.592% |
| Moolec Science SA | 905.04 Thousand USD | -1090360.296% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -447889.106% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -4837743.137% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -8224233.333% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -2512.911% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -5195.374% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -40423.939% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -401079.001% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -829942.052% |
| Lumos Pharma, Inc. | 2.05 Million USD | -481089.664% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -24133.653% |
| Palisade Bio, Inc. | 250 Thousand USD | -3947580.0% |
| Nutriband Inc. | 2.08 Million USD | -473171.651% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -63774.183% |
| Neurogene Inc. | - USD | -Infinity% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| HCW Biologics Inc. | 2.84 Million USD | -347187.664% |
| XOMA Corporation | 4.75 Million USD | -207323.287% |
| Nektar Therapeutics | 90.12 Million USD | -10850.933% |
| Arvinas, Inc. | 78.5 Million USD | -12472.229% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -22357.051% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -318878.668% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -1508951.988% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -563532.21% |
| Synlogic, Inc. | 3.37 Million USD | -292667.725% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -2682644.504% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -49387.038% |
| Krystal Biotech, Inc. | 50.69 Million USD | -19366.262% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -6658.198% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -181085.974% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -2194923.765% |
| MannKind Corporation | 198.96 Million USD | -4860.344% |
| Ikena Oncology, Inc. | 9.16 Million USD | -107642.358% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -8599.163% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -3361.141% |
| Mural Oncology plc | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -19577.4% |
| REGENXBIO Inc. | 90.24 Million USD | -10836.371% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -442361.847% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -133647.12% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -1307078.808% |
| Longeveron Inc. | 709 Thousand USD | -1391888.717% |
| Repare Therapeutics Inc. | 51.13 Million USD | -19201.038% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -693.768% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -85126.252% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -4699519.048% |
| Denali Therapeutics Inc. | 330.53 Million USD | -2885.862% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -60458.541% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -365020.237% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -6474478.495% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -66051.887% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -1462003.704% |
| OmniAb, Inc. | 34.16 Million USD | -28787.718% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -46338.923% |
| Lipocine Inc. | -2.85 Million USD | 346288.357% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -440687.837% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -11861.072% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -11315.418% |
| Ocugen, Inc. | 6.03 Million USD | -163405.633% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -853637.024% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -27250.626% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -164326.213% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 2.03 Million USD | -483921.579% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -751.483% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -36693.796% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -1595.675% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -78258.079% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -2068914.675% |
| Iterum Therapeutics plc | - USD | -Infinity% |